[{“box”:0,”content”:”[if 992 equals=”Open Access”]n
n
Open Access
nn
n
n[/if 992]n
n
n
n
n
n
Merlin N. J, Anshad AS, Asheeta A, Shaiju S Dharan,
n
- n t
n
n
n[/foreach]
n
n[if 2099 not_equal=”Yes”]n
- [foreach 286] [if 1175 not_equal=””]n t
- Professor and HOD, Student, Associate Professor, Principal Department of Pharmacology, Ezhuthachan College of Pharmaceutical Sciences, Department of Pharmacology, Ezhuthachan College of Pharmaceutical Sciences, Department of Pharmacology, Ezhuthachan College of Pharmaceutical Sciences, Ezhuthachan College of Pharmaceutical Sciences Kerala, Kerala, Kerala, Kerala India, India, India, India
n[/if 1175][/foreach]
n[/if 2099][if 2099 equals=”Yes”][/if 2099]n
Abstract
nCardiovascular diseases (CVDs) represent a formidable global health challenge, demanding innovative strategies for timely detection, effective management, and continuous monitoring. This paper delves into the transformative potential of digital health interventions (DHIs), such as telemedicine and remote monitoring, in reshaping cardiovascular care paradigms. DHIs offer unparalleled accessibility, convenience, and personalized attention, thereby promising to revolutionize traditional approaches to cardiovascular health management. One of the foremost advantages of DHIs lies in their ability to facilitate early intervention, which is crucial in preventing adverse cardiovascular events. Through telemedicine, healthcare providers can remotely assess patients’ cardiac health status, enabling prompt adjustments to treatment plans or interventions as necessary. This proactive approach not only enhances patient outcomes but also mitigates the risk of disease progression. Furthermore, DHIs foster heightened patient engagement by empowering individuals to actively participate in their healthcare journey. With remote monitoring tools, patients can conveniently track vital signs, medication adherence, and lifestyle behaviors, fostering a sense of ownership over their health. This heightened engagement often translates into improved treatment adherence and better long-term health outcomes. Cost-effectiveness is another compelling aspect of DHIs, potentially alleviating the financial burden associated with traditional healthcare delivery models. By reducing the need for frequent in-person visits and hospitalizations, DHIs offer a more efficient allocation of resources while minimizing healthcare costs for both patients and providers. However, the widespread implementation of DHIs is not without its challenges, particularly concerning technology infrastructure and data security. Despite these obstacles, DHIs hold immense promise in transforming cardiovascular healthcare by promoting proactive, personalized, and patient-centric approaches. Embracing these innovations heralds a new era of proactive, personalized, and accessible cardiovascular care, ultimately leading to improved population health and reduced disease burden.
n
Keywords: Digital health interventions, cardiovascular diseases, tele medicine, remote monitoring, digital health interventions.
n[if 424 equals=”Regular Issue”][This article belongs to Research & Reviews: A Journal of Pharmacology(rrjop)]
n
n
n
n
n
nn[if 992 equals=”Open Access”] Full Text PDF Download[/if 992] n
nn[if 379 not_equal=””]n
Browse Figures
n
n[/if 379]n
References
n[if 1104 equals=””]n
1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. Journal of the American college of cardiology. 2020 Dec 22;76(25):2982-3021.
2. Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature Reviews Clinical Oncology. 2020 Nov;17(11):687-705.
3. Marvel FA, Spaulding EM, Lee MA, Yang WE, Demo R, Ding J, Wang J, Xun H, Shah LM, Weng D, Carter J. Digital health intervention in acute myocardial infarction. Circulation: Cardiovascular Quality and Outcomes. 2021 Jul;14(7):e007741.
4. Omboni S, Padwal RS, Alessa T, Benczúr B, Green BB, Hubbard I, Kario K, Khan NA, Konradi A, Logan AG, Lu Y. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connected health. 2022 Jan 1;1:7.
5. Piskulic D, McDermott S, Seal L, Vallaire S, Norris CM. Virtual visits in cardiovascular disease: a rapid review of the evidence. European Journal of Cardiovascular Nursing. 2021 Nov 1;20(8):816-26.
6. Kario K. Management of hypertension in the digital era: small wearable monitoring devices for remote blood pressure monitoring. Hypertension. 2020 Sep;76(3):640-50.
7. Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: evidence from the field. Journal of the American Medical Informatics Association. 2020 Jul;27(7):1132-5.
8. Health Quality Ontario. Remote monitoring of implantable cardioverter-defibrillators, cardiac resynchronization therapy and permanent pacemakers: a health technology assessment. Ontario health technology assessment series. 2018;18(7):1.
9. Moukhtar Hammad MA, El-Achkar A, Nguyen T, Barham DW, Tran J, Jenkins L, Yafi FA. The pandemic, telemedicine, and andrology: what have we learned?. Sexual Medicine Reviews. 2023 Jul;11(3):231-9.
10. Dalloul AH, Miramirkhani F, Kouhalvandi L. A Review of Recent Innovations in Remote Health Monitoring. Micromachines. 2023 Nov 26;14(12):2157.
11. Rao A, Bennett S. Cardiac implantable electronic devices: an overview for primary care. British Journal of General Practice. 2022 Aug 1;72(721):402-4.
12. Kulkarni S, Glover M, Kapil V, Abrams SM, Partridge S, McCormack T, Sever P, Delles C, Wilkinson IB. Management of hypertensive crisis: British and Irish Hypertension Society Position document. Journal of Human Hypertension. 2023 Oct;37(10):863-79.
13. Badyal DK, Lata H, Dadhich AP. Animal models of hypertension and effect of drugs. Indian Journal of pharmacology. 2003 Nov 1;35(6):349-62.
14. Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. The Journal for Nurse Practitioners. 2021 Feb 1;17(2):218-21.
15. Yang YT, Kozhimannil KB. Medication abortion through telemedicine: implications of a ruling by the Iowa Supreme Court. Obstetrics & Gynecology. 2016 Feb 1;127(2):313-6.
nn[/if 1104][if 1104 not_equal=””]n
- [foreach 1102]n t
- [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]
n[/foreach]
n[/if 1104]
nn
nn[if 1114 equals=”Yes”]n
n[/if 1114]
n
n
n
n
n
n
n
| Volume | 14 | |
| [if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] | 02 | |
| Received | March 18, 2024 | |
| Accepted | June 1, 2024 | |
| Published | July 23, 2024 |
n
n
n
n
n
n nfunction myFunction2() {nvar x = document.getElementById(“browsefigure”);nif (x.style.display === “block”) {nx.style.display = “none”;n}nelse { x.style.display = “Block”; }n}ndocument.querySelector(“.prevBtn”).addEventListener(“click”, () => {nchangeSlides(-1);n});ndocument.querySelector(“.nextBtn”).addEventListener(“click”, () => {nchangeSlides(1);n});nvar slideIndex = 1;nshowSlides(slideIndex);nfunction changeSlides(n) {nshowSlides((slideIndex += n));n}nfunction currentSlide(n) {nshowSlides((slideIndex = n));n}nfunction showSlides(n) {nvar i;nvar slides = document.getElementsByClassName(“Slide”);nvar dots = document.getElementsByClassName(“Navdot”);nif (n > slides.length) { slideIndex = 1; }nif (n (item.style.display = “none”));nArray.from(dots).forEach(nitem => (item.className = item.className.replace(” selected”, “”))n);nslides[slideIndex – 1].style.display = “block”;ndots[slideIndex – 1].className += ” selected”;n}n”}]